PD-029 Phase II trial: melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors. (March 2019) - Borbalas, A. Lozano; Marruecos, J.; Rubio-Casadevall, J.; Farre, N.; Lopez-Pousa, A.; Gomez-Millan, J.; Toledo, M.D.; Morera, R.; Glaria, L.; Planas, I.; Mesia, R.; Lanzuela, M.; et al.